MissionIR Articles
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Maintains String of Profitability in 15 Consecutive Quarters
Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, continues to grow every quarter, returning value to shareholders. “While many companies languished through the COVID-19 pandemic, GMGI maintained…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Announces Approval of NCIB by TSX Venture Exchange
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, today announced that the TSX Venture Exchange (“TSXV”) has approved the company’s Normal Course Issuer Bid (“NCIB”). The NCIB will allow EverGen to…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Aims to Deliver Safer Alternative for Nicotine Experience
Lexaria Bioscience Corp. (NASDAQ: LEXX) will soon begin a human clinical study, NIC-H22-1, to compare its DehydraTECH-nicotine pouch performance with that of existing brands such as ON! and Zyn, currently available in the U.S. “Animal…
-
SRAX Inc. (NASDAQ: SRAX) Seeks to Become the Information Venue of Choice for Today’s Retail Investor Community
Retail investment has boomed of late, with retail investors accounting for 23% of all U.S. equity market transactions in 2021 SRAX and investor intelligence platform, Sequire, have sought to service the informational needs of a…
-
Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs
Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies…
-
Nemaura Medical Inc.’s (NASDAQ: NMRD) sugarBEAT(R) Wearable CGM Device Targets Billion-Dollar Global Diabetes Market
Global diabetes-related healthcare expenses are estimated at $966 billion in 2021 A recent report reveals 537 million adults currently live with diabetes, projected to rise to 643 million by 2030 and 783 million by 2045 …
-
SRAX Inc. (NASDAQ: SRAX) Unveil Bullish 2022 Guidance: Update Investors on Ongoing Share Buybacks and Preference Share Payouts
SRAX recently provided the market with its 2022 revenue forecast, guiding of $46-48 million in top-line revenues which surpassed street estimates of $42.52 million The company also seized upon the opportunity to update investors on…
-
Nemaura Medical Inc. (NASDAQ: NMRD) Set to Capitalize on Glucose Monitoring Sector’s Exponential Growth Rate
The blood glucose monitoring system sector is expected to grow to a value of $27.2 billion by 2026, expanding at a CAGR of 9.6% between 2021-2026 Over 420 million people around the globe currently have…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces New Chief Strategy Officer
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Vessel founder and CEO James Chose as its new chief strategy officer. Choe brings impressive experience to…
-
MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX), Convertible Note Investor Collaborate to Mitigate Immediate Conversion Risk
GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, today announced that it has entered into an agreement with respect to the $100 million convertible note financing, originally entered into on Nov. 2, 2021,…
-
Growth Capital Acquisition Corp.’s (NASDAQ: GCAC) Management Set to Complete Business Combination with Cepton Technologies in the First Quarter of 2022
Growth Capital Acquisition Corp. agreed to combine with Cepton Technologies Inc, a Silicon Valley firm focused on the development of lidar technology in August 2021 The deal, which is expected to close on February 9,…
-
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Vision Strengthens Company’s Position in Emerging Wellness Trend
Psychedelics pose potential as effective treatments for mental-health issues such as depression, anxiety, and substance abuse Well+Good says psychedelics “poised to change the course of mental health treatment” Cybin working to combine novel psychedelic molecules with controllable…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Targeting Increased Revenue and Margins with Strategic Focus on Vertical Integration
RWB recently reported its Q3 2021 financial results in which revenues grew 93% YOY The company is pursuing vertical integration in multiple states, including Florida, California, and Michigan In Florida, RWB has launched cultivation operations…
-
MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Names Industry Veteran as COO
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, has appointed Dr. Arash (Ash) Ghadar as chief operating officer. Currently a non-executive…
-
Flora Growth Corp. (NASDAQ: FLGC) Enters Cannabis Beverages Market, Extends Portfolio of Luxury Products with Tonino Lamborghini Licensing Agreement
Flora Growth recently entered into a licensing agreement to produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia, with an initial focus on the U.S. market The company will produce the product…
-
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Touts Highlights of ‘Transformative’ Second-Quarter Performance
Report notes significant and swift advancements in company R&D pipeline and overall business Preliminary data indicates CYB003 may provide significant treatment benefits that address limitations of oral psilocybin CYBN programs and new psychedelic chemical entities…
-
Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q2-2021 Results, Signs Global Commercial Contract with MySugarWatch DuoPack Limited
NMRD releases fiscal Q2-2021 results, provides business update Highlights include pending revenue recognition, global commercial contract with MySugarWatch DuoPack Limited, appointment of Dr. Osama Hamdy to advisory board Company operates at intersection of $59 billion…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Schedules November 29th for Q3 2021 Financials Release; November 30th for Earnings Discussion
RWB is set to release its Q3 financial results on November 29, 2021 A conference call will follow this release on November 30, 2021, at 5:00 PM ET to discuss these results, the company’s operations,…
-
InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs
InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and…
-
Insurtech Market Seen as a Major Driver for Big Data and Mobile Tech Innovator FingerMotion Inc. (FNGR)
U.S.-based FingerMotion is a technology innovator focused on smart communication applications in China’s mobile-hungry billion-plus population The company’s big data services are relatively new in development but already play a significant role in the insurtech…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) to Debut Mudra Experience Studio at MWC Barcelona 2026
- MissionIRNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Featured by Streetwise Reports for Rapid Revenue Growth and Fintech Expansion
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints Lynne Kelley as Chief Medical Officer
- MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Completes $1M AI Edge System Delivery to U.S. Government in 15 Days
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints Prof. Joshua C. Brown As Chief Medical Innovation Officer